ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Ceftazidime Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2025-11-14 · last update 2025-11-14

Manufacturers: Hospira, Inc., a Pfizer Company

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Tazicef, Injection, 1 g (NDC 0409-5092-16)Hospira, Inc., a Pfizer CompanyTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 11/14/2025
Updated 11/14/2025
Discontinued 11/14/2025
Tazicef, Injection, 2 g (NDC 0409-5093-11)Hospira, Inc., a Pfizer CompanyTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 11/14/2025
Updated 11/14/2025
Discontinued 11/14/2025

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)